LYB vs VRCA · P/E 21, rev $16.37B vs rev $10.9M
LyondellBasell Industries NV (LYB) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the LYB and VRCA stock pages for the full models.
Not investment advice.